Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:36:57.387Z.
Calculation as of: 2026-10-06T21:36:57.387Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
EARNINGS YIELD
N/A
Market Cap
$1.75B
Earnings Yield
N/A
TTM Avg
0.01%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$1.74B
Earnings Yield
N/A
TTM Avg
0.90%
3Y Avg
0.90%
5Y Avg
0.90%
Market Cap
$1.74B
Earnings Yield
2.23%
TTM Avg
0.99%
3Y Avg
0.99%
5Y Avg
0.99%
Market Cap
$1.81B
Earnings Yield
3.61%
TTM Avg
2.74%
3Y Avg
2.29%
5Y Avg
2.27%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.77B | N/A | N/A | N/A | N/A |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | N/A | 0.01% | 0.01% | 0.01% |
| Novocure Ltd (NVCR)vs › | $1.74B | N/A | 0.11% | 0.11% | 0.11% |
| Absci Corporation (ABSI)vs › | $1.74B | N/A | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | N/A | 0.90% | 0.90% | 0.90% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 2.23% | 0.99% | 0.99% | 0.99% |
| Xencor, Inc. (XNCR)vs › | $1.81B | N/A | 3.26% | 2.62% | 2.36% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 3.61% | 2.74% | 2.29% | 2.27% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.81B | N/A | 1.68% | 5.59% | 5.05% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
